Portrazza (Necitumumab), an IgG1 Monoclonal Antibody, FDA Approved for Advanced Squamous Non–Small-Cell Lung Cancer

Benzer Materyaller

• Nucala (Mepolizumab): First IL-5 Antagonist Monoclonal Antibody FDA Approved for Maintenance Treatment of Patients with Severe Asthma
  Yazar:: Fala, Loretta
  Baskı/Yayın Bilgisi: (2016)
• Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.
  Yazar:: Steplewski, Z, ve diğerleri
  Baskı/Yayın Bilgisi: (1988)
• Quantification of IgG monoclonal antibody clearance in tissues
  Yazar:: Eigenmann, Miro J., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Impact of IgG subclass on monoclonal antibody developability
  Yazar:: Paul Cain, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-12-01)
• Modulation of the murine immune response to human IgG by complexing with monoclonal antibodies. II. Antibody responses to idiotopes of the human IgG paraprotein and of the mouse monoclonal antibodies.
  Yazar:: Ling, N R, ve diğerleri
  Baskı/Yayın Bilgisi: (1987)